DIVERT: Randomised study assessing the effect of intracorporeal versus extracorporeal urinary diversion on hospital length of stay in patients undergoing robotic assisted cystectomy

Department of Urology Royal Prince Alfred Hospital (RPAH)0 个研究点目标入组 72 人开始时间: 2022年4月26日最近更新: 2024年6月10日

适应症

试验速览

暂无简介。

•To be eligible to enter the study all patients must satisfy the following criteria:
•1. Adult aged 18 to 80 years of age
•2. Undergoing Robot-Assisted Radical Cystectomy (RARC) for bladder cancer (and requiring either ileal conduit or neobladder) or RARC for non-functioning lower urinary tract requiring urinary diversion
•3. Oncologically suitable for robotic cystectomy ie localised bladder cancer
•Non-invasive disease - Certain high risk high grade NMIBC T1 disease
•MIBC T2-T4N1M0
•4. Clinically suitable for robotic cystectomy ie deemed surgical fit for a major operation as deemed by anaesthetic pre-operative assessment
•5. Cognitively able to give written informed consent for participation
•6. Elective procedure
•7. Salvage cystectomy cases will be included where primary treatment with radiation has failed and the patient is oncologically and clinically suitable for robotic cystectomy.
•8. Concomitant urethrectomy patients will be included

•Patients will be excluded if they present the following exclusion criteria:
•1. The patient lacks the ability to consent for themselves
•2. Patient or tumour factors precluding robotic surgery (including not medically fit for surgery, extensive previous abdominal surgery, metastatic disease or potentially unresectable locally advanced disease)

发起方

Department of Urology Royal Prince Alfred Hospital (RPAH)